অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - lenalidomide, quantity: 15 mg - capsule - excipient ingredients: povidone; mannitol; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; gelatin; titanium dioxide; indigo carmine; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - multiple myeloma (mm) lenalidomide is indicated for the treatment of multiple myeloma. ,myelodysplastic syndromes (mds) lenalidomide is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,mantle cell lymphoma (mcl) lenalidomide is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - lenalidomide, quantity: 10 mg - capsule - excipient ingredients: povidone; mannitol; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; gelatin; iron oxide yellow; titanium dioxide; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - multiple myeloma (mm) lenalidomide is indicated for the treatment of multiple myeloma. ,myelodysplastic syndromes (mds) lenalidomide is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,mantle cell lymphoma (mcl) lenalidomide is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - lenalidomide, quantity: 7.5 mg - capsule - excipient ingredients: povidone; mannitol; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; gelatin; titanium dioxide; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - multiple myeloma (mm) lenalidomide is indicated for the treatment of multiple myeloma. ,myelodysplastic syndromes (mds) lenalidomide is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,mantle cell lymphoma (mcl) lenalidomide is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - lenalidomide, quantity: 5 mg - capsule - excipient ingredients: povidone; mannitol; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; gelatin; titanium dioxide; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - multiple myeloma (mm) lenalidomide is indicated for the treatment of multiple myeloma. ,myelodysplastic syndromes (mds) lenalidomide is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,mantle cell lymphoma (mcl) lenalidomide is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 20 mg - tablet, film coated - excipient ingredients: hypromellose; iron oxide red; titanium dioxide; croscarmellose sodium; sodium lauryl sulfate; microcrystalline cellulose; lactose monohydrate; purified talc; macrogol 4000 - rivaroxaban is indicated for:,? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 15 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; magnesium stearate; titanium dioxide; lactose monohydrate; iron oxide red; croscarmellose sodium; macrogol 4000; microcrystalline cellulose; hypromellose - rivaroxaban is indicated for:,? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - rivaroxaban, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; iron oxide red; sodium lauryl sulfate; macrogol 4000; croscarmellose sodium; titanium dioxide; hypromellose; microcrystalline cellulose - rivaroxaban is indicated for:,? prevention of venous thromboembolism (vte) in adult patients who have undergone major orthopaedic surgery of the lower limbs (elective total hip replacement, treatment for up to 5 weeks; elective total knee replacement, treatment for up to 2 weeks).

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 116 mg (equivalent: dasatinib, qty 100 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; hydrogenated castor oil; lactose; hypromellose; croscarmellose sodium; titanium dioxide; triacetin; silicon dioxide - reddy's-dasatinib is indicated for the treatment of adults aged 18 years or over with:,- newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. - philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,reddy's-dasatinib is indicated for the treatment of paediatric patients with:,- newly diagnosed ph+ all in combination with chemotherapy.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 58 mg (equivalent: dasatinib, qty 50 mg) - tablet, film coated - excipient ingredients: titanium dioxide; silicon dioxide; lactose; microcrystalline cellulose; hydrogenated castor oil; magnesium stearate; croscarmellose sodium; hypromellose; triacetin - reddy's-dasatinib is indicated for the treatment of adults aged 18 years or over with:,- newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. - philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,reddy's-dasatinib is indicated for the treatment of paediatric patients with:,- newly diagnosed ph+ all in combination with chemotherapy.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 81.2 mg (equivalent: dasatinib, qty 70 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; silicon dioxide; croscarmellose sodium; titanium dioxide; hypromellose; lactose; magnesium stearate; triacetin; hydrogenated castor oil - reddy's-dasatinib is indicated for the treatment of adults aged 18 years or over with:,- newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. - philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,reddy's-dasatinib is indicated for the treatment of paediatric patients with:,- newly diagnosed ph+ all in combination with chemotherapy.